Oppenheimer Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $20
Piper Sandler Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $25
Tactile Systems Technology (TCMD) Gets a Buy From Piper Sandler
Buy Rating Affirmed for Tactile Systems Technology on Product Innovation and Strong Financial Outlook
Oppenheimer Remains a Buy on Tactile Systems Technology (TCMD)
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)
Analysts Are Bullish on These Healthcare Stocks: Bicycle Therapeutics (BCYC), Tactile Systems Technology (TCMD)
BTIG Keeps Their Buy Rating on Tactile Systems Technology (TCMD)
Tactile Systems Technology (TCMD) Gets a Buy From BTIG
Oppenheimer Sticks to Its Buy Rating for Tactile Systems Technology (TCMD)
Piper Sandler Cuts Tactile Systems Technology Price Target to $23 From $30, Maintains Overweight Rating
Positive Growth Prospects for Tactile Systems Technology: An Analyst's Buy Rating Amid Airway Clearance Challenges
BTIG Sticks to Their Buy Rating for Tactile Systems Technology (TCMD)
Oppenheimer Maintains Outperform on Tactile Systems Tech, Raises Price Target to $30
Tactile Systems Tech Analyst Ratings
Tactile Systems Technology (TCMD) Gets a Buy From Piper Sandler
Piper Sandler Remains a Buy on Tactile Systems Technology (TCMD)
Analysts Are Bullish on These Technology Stocks: Tactile Systems Technology (TCMD), Broadcom (AVGO)
Piper Sandler Adjusts Price Target on Tactile Systems Technology to $30 From $25, Keeps Overweight Rating
Piper Sandler Maintains Overweight on Tactile Systems Tech, Raises Price Target to $30